Position of Beta-blockers in the Treatment of Hypertension Today: An Indian Consensus
Beta-blockers, including nebivolol, can be considered initial-line therapy for HTN management in real-life settings in India and nebivolol is preferred because of its two important properties: highest beta-1 selectivity and endothelial-dependent vasodilation.
Authors
- Kamal Sharma (ORCID: https://orcid.org/0000-0001-5866-2566)
- Thomas Alexander (ORCID: https://orcid.org/0000-0001-5402-9165)
- Jamshed Dalal (ORCID: https://orcid.org/0000-0001-7571-5674)
- Amit Kumar (ORCID: https://orcid.org/0000-0002-7326-0036)
- Devanu Ghosh Roy
- Saumitra Ray
- JPS Sawhney
- JC Mohan
- Jabir Abdullakutty (ORCID: https://orcid.org/0000-0002-6970-6461)
Institutions
- KPC Medical College and Hospital (IN)
- Ahmedabad Civil Hospital (IN)
- Lourdes Hospital (IN)
- Kovai Medical Center and Hospital (IN)
- Sir Ganga Ram Hospital (IN)
- Jaipur Golden Hospital (IN)
- Kokilaben Dhirubhai Ambani Hospital (IN)
- Apollo Hospitals (IN)
- Woodlands Hospital (GB)
- Sir Ganga Ram Hospital (PK)
Publication Details
- Journal
- Journal of the Association of Physicians of India
- Published
- 2024-10-01
- DOI
- https://doi.org/10.59556/japi.72.0715
- Citations
- 4
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.61